Blood Platelets Market - By Platelet Type, By Application, By End Use - Global Forecast, 2025 - 2034

Blood Platelets Market Size

The global blood platelets market size was estimated at USD 5.9 billion in 2024. The market is expected to grow from USD 6.2 billion in 2025 to USD 8.8 billion in 2034, at a CAGR of 3.9% during the forecast period, according to the latest report published by Global Market Insights Inc. The market is driven by growing demand for blood transfusions, rise in awareness regarding blood donations and platelet transfusions, increasing prevalence of chronic and blood-related disorders, and a rising number of surgical procedures, among other factors.

Advancements in platelet storage and processing technologies, increasing partnerships and collaborations among biotech firms, and the development of artificial and lyophilized platelets is among the key factors propelling the product demand. The American National Red Cross, the European Blood Alliance (EBA), the Japanese Red Cross Society, the Indian Red Cross Society, and America's Blood Centers are among the leading players operating in the market. These players mainly focus on product innovation, adoption of advanced technologies, and collaboration with local healthcare providers to further their geographical expansion plans, among others.
 

The market reached USD 5.6 billion in 2023 from USD 5 billion in 2021. The increasing prevalence of chronic diseases such as cancer, anemia, and thrombocytopenia is driving the continued demand for platelet transfusions. For instance, according to the data published by the International Agency for Research on Cancer (IARC), the number of new cancer cases is anticipated to reach over 35 million per year in 2050 from around 20 million in 2022. Chronic illnesses typically require multiple interventions, for which platelets are necessary. The aging population and health complications from lifestyle choices further contribute to the need for platelets. Various healthcare providers, including hospitals and clinics, have become more focused on platelets in order to address complications caused by excessive bleeding or clotting disorders. As patient volumes increase, hospitals and clinics are investing in blood banking infrastructure, advanced storage technologies, and donor recruitment and retention programming.
 

Additionally, blood transfusions are important for trauma treatment, surgery and surgical procedures, and treating patients with hematological disorders. Platelets are particularly important for clotting and prevention of bleeding during these treatments. Increasing hospitalizations, complex medical procedures, and emergency admissions have all contributed to the worldwide increase in transfusions. Hospital systems are expanding blood collection programs and adopting advanced technology to meet these increased needs. The increase in transfusions prompts hospitals to partner with blood centers to ensure timely availability for transfusion. This trend is expected to continue to persist as medical treatment becomes further advanced and complex with clinical use of platelets.
 

Further, public awareness campaigns, social media initiatives, and government programs have increased awareness of blood and platelet donations. For example, as per a recently published article by the Association for the Advancement of Blood & Biotherapies (AABB), January is designated as the National Blood Donor Month in the U.S. Started in 1970, this program is observed to spread awareness and encourage more people to donate blood in the country. With greater awareness of the life-saving impact of donations, voluntary donor participants has increased, resulting in a more stable platelet supply across many regions.
 

Awareness campaigns also take time to educate communities on how urgently platelets are needed to care for cancer patients and in surgical situations. This increased awareness allows more effective management of inventory and platelet availability in urgent situations. Furthermore, as the number of people committing to donate platelets on a regular basis rises, the healthcare system is able to maintain supply chains that are more consistent.
 

Blood platelets, or thrombocytes, are small, disc-shaped cell fragments in the blood that play a crucial role in clotting, preventing excessive bleeding, and supporting wound healing processes.
 

Blood Platelets Market Trends

Increasing automation in platelet collection, growing focus on artificial platelets and biotech solutions, integration of digital tools for inventory management, and rising demand for platelet-rich plasma (PRP) therapies are among the key trends shaping market growth.
 

• PRP is increasingly being utilized in regenerative medicine, orthopedics, and cosmetic applications and is considered a potential enhancement to tissue repair and wound healing. This enhancement improves tissue healing and repair to consider newer applications beyond traditional transfusions while maximizing revenue potential for sources of platelets.
   
• Additionally, the pace of research into synthetic platelets and lyophilized (freeze-dried) products is accelerating. Both alternatives seek to eliminate donor dependency and storage concerns and offer durability and faster use in emergency situations.
   
• Further, the automated apheresis systems have received significant acceptance in the research drug development cycle for assured safety, product yield improvement, and donor fatigue reduction. The apheresis system is being utilized at hospitals and blood facilities for improving efficiency and adhering to strict compliance standards.
   
• Moreover, to limit shortages and optimize distribution, blood centers are implementing AI- and IoT-based platforms for real-time monitoring of platelet inventories, especially in areas with irregular demand.
   

Blood Platelets Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

In 2021, the market was valued at USD 5 billion and grew to USD 5.3 billion in 2022, reaching USD 5.6 billion by 2023. Rising demand for personalized medicine and targeted therapies and increasing number of surgical and trauma cases are among the key variables contributing to industry growth.
 

Based on platelet type, the global market is segmented into whole-blood derived platelet and apheresis derived platelets. The apheresis derived platelets segment accounted for a leading share of 53.1% in 2024. Rise in number of surgical procedures is anticipated to fuel the industry growth. The segment is expected to exceed USD 4.6 billion by 2034, growing at a CAGR of 3.8% during the forecast period.
 

• Platelets collected directly from a single donor through apheresis systems are obtained using automated apheresis machines, which separate the platelets from the whole blood while returning the remaining blood components. This process yields a greater volume of platelets per donation and reduces the risk of alloimmunization and transfusion-related infections.
   
• Platelet apheresis is preferred for patients who require multiple transfusions, such as cancer patients receiving chemotherapy or patients undergoing bone marrow transplantation.
   
• Additionally, platelets collected through apheresis are considerably more costly and time-consuming than platelets collected through whole blood donation, but the safety and compatibility benefits outweigh the extra cost. The development of advanced apheresis technology and strict transfusion standards is expected to support the healthcare system's growth.
   
• The whole-blood-derived platelet segment was valued at USD 2.8 billion in 2024. Platelets derived from donated whole blood units are separated during component processing. This is a practical approach for regions with high donation rates and limited access to advanced technologies.
   
• Further, whole-blood-derived platelets are usually pooled from multiple donors to provide therapeutic doses (financially feasible for budget-constrained hospitals) and therefore have a slightly higher incidence of transfusion reactions compared to apheresis platelets.
   
• Moreover, whole-blood-derived platelets are essential in emergencies and in low-resource environments, offering timely access to platelets for surgery, trauma cases, and patients with bleeding disorders.
   

Based on application, the global blood platelets market is segmented into hemophilia, thrombocytopenia, perioperative indications, platelet function disorders, hemato-oncology, and other applications. The thrombocytopenia segment accounted for a leading share and was valued at USD 2.6 billion in 2024.
 

• Thrombocytopenia is a condition where the patient has a low platelet count and is therefore among the foremost applications that drive the demand for platelet transfusion in hospitals and clinics. Patients with thrombocytopenia often suffer from excessive bleeding and require an immediate transfusion of platelets for restoration of hemostatic function.
   
• It is majorly observed in patients who have received chemotherapy, those who have bone marrow disorders, or those who have autoimmune disorders. In addition, the increasing cases of cancer and hematological disorder incidence worldwide have driven the demand in the last few years.
   
• Ongoing advances in pathogen reduction and platelet storage mechanisms facilitate timely platelet availability and enhance thrombocytopenia treatment in the overall blood platelet market.
   
• The hemato-oncology segment was valued at USD 1.5 billion in 2024. The field of hemato-oncology encompasses the treatment of blood cancers such as leukemia, lymphoma, and myeloma, and platelet transfusions are among the critical aspects of treatment in chemotherapy-induced thrombocytopenia. Patients undergoing intensive cancer treatments are expected to require multiple platelet transfusions in order to minimize the risk of bleeding complications.
   
• Furthermore, enhanced therapies and increased survival rates have extended both the duration and frequency of transfusion needs of hemato-oncologic patients. With an expanding worldwide cancer care system, hemato-oncology is expected to remain a key area for generating platelet demand in the healthcare system.
   
• The platelet function disorders segment is anticipated to record the highest growth with a CAGR of 4.3% over the forecast period. Platelet function disorders, including inherited disorders such as Glanzmann's thrombasthenia and acquired dysfunctions, require platelet transfusions to limit the risk of bleeding and bleeding complications.
   
• Platelet function disorders can inhibit platelet aggregation and clot formation, which can complicate surgical or trauma situations when a transfusion of platelets is indicated.
   
• Hospitals often have a specialized inventory of platelets for this particular condition. The rise in awareness of such conditions and the ability to diagnose them has led to the identification of more patients with these types of disorders, increasing the demand for specific platelet therapies.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the blood platelets market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment accounted for the leading market share of 80.4% in 2024 due to high patient footfall and cost affordability.
 

• Hospitals are the largest end-use segment for platelet transfusions, as they are the preferred settings for various treatments, surgical procedures, trauma cases, and chronic diseases. Hospitals generally have sizeable blood banks that can store platelets and have advanced storage technologies in place to deliver transfusable platelets in an emergency.
   
• In addition, they have also implemented automated inventory systems and pathogen-reduction technology to meet strict safety-related requirements. With growing surgical volume and increasingly complicated medical procedures, hospitals are expected to continue to drive demand for platelet transfusions.
   
• Further, the centralized structure combined with the ability to handle large patient volumes makes hospitals the major end user in the platelet transfusion industry worldwide.
   
• Moreover, the ambulatory surgical centers segment was valued at USD 614.7 million in 2024. Ambulatory surgical centers are witnessing significant growth due to the rise in preference for outpatient procedures.
   
• Additionally, various elective surgeries and orthopedic interventions are conducted in ASCs, and they often need platelet transfusions to avoid bleeding complications. These facilities strive to be cost-effective and quick-turnaround facilities, which increases the demand for a reliable primary supply chain for platelets.
   

Looking for region specific data?

Download Free PDF

 North America Blood Platelets Market

North America market accounted for significant share of 26.8% in 2024 in the global market and is anticipated to show notable growth over the forecast period.
 

• North America accounts for a significant share of the blood platelet market due to highly developed healthcare infrastructure and strong awareness among citizens related to blood donation. The region has a strong demand for blood platelets due to cancer treatments, trauma care, and complex surgeries.
   
• Additionally, technological innovations such as automated apheresis systems and pathogen reduction technologies are widely adopted, ensuring safety and efficiency. The U.S. has extensive blood platelet donation networks in the community, such as the American Red Cross Society and America’s Blood Centers, supported by government funding promoting voluntary donations.
   
• Further, the growing prevalence of chronic diseases and the aging population are leading to high blood platelet consumption levels in the region. In addition, Canada also has a similar centralized system through Canadian Blood Services for blood donation across its provinces.
   

The U.S. blood platelets market was valued at USD 1.42 billion and USD 1.47 billion in 2021 and 2022, respectively. In 2024 the market size was valued at USD 1.57 billion from USD 1.52 billion in 2023. Increasing automation in platelet collection and integration of digital tools for inventory management is projected to fuel the market growth.
 

• The U.S. is among the key sources of platelet demand globally, fueled by high surgical volume, growth in cancer treatment, and a rise in trauma cases. For example, the American Red Cross encourages people to donate blood and spread awareness, as every 2 seconds someone in the U.S. needs blood or platelets. Nationwide organizations such as the American Red Cross and the American Association of Blood Banks manage large donor networks and advanced technology to collect sufficient product via platelet apheresis.
   
• Additionally, well-established regulatory scrutiny ensures the safety and quality of transfusion practices. A consistent rise in the use of platelet-rich plasma therapies in regenerative medicine has also resulted in increased platelet demand.
   
• Further, the focus on digital platforms for donor engagement as well as inventory control has improved overall process efficiency. Moreover, owing to factors such as an aging population, technological advancements, and increasing chronic diseases across age groups, the use of platelets in hospitals and ambulatory surgery centers is on the rise, propelling market growth.
   

Europe Blood Platelets Market

Europe accounted for a substantial share of the global market and was valued at USD 961 million in 2024.
 

• Europe holds a substantial presence in the platelet industry, backed by centralized blood service organizations and rigorous safety practices. Countries such as Germany, France, the UK, Italy, and Spain are the leaders in regional supply through their national Red Cross societies or other associations.
   
• The European Blood Alliance promotes collaboration and best practices across member states to help harmonize procedures and promote research in transfusion medicine. Increased surgical procedures, cancer care, and the growing number of patients suffering from hemophilia are all contributing to upward trends in platelet demand.
   
• In addition, technologies such as platelet pathogen-reduction systems and automated blood component collection devices are routinely employed. Public awareness campaigns and voluntary donor programs help maintain a stable supply.
   
• Further, the region's commitment to improving sustainability and fostering innovation reinforces Europe’s position as a key contributor to platelet availability in the global market.
   

Germany held significant share of the European blood platelets market, showcasing strong growth potential.
 

• Germany is among the major players in European platelet collection and transfusion services. The German Red Cross has a nationwide infrastructure in place to cover the entire country. High-quality healthcare and advanced apheresis technology (for automated platelet collection) support the effective supply of platelets produced.
   
• Additionally, the increase in hematological disorders and cancer treatments has led to a noticeable rise in platelet demand, while elective surgeries have further fueled overall consumption.
   
• Further, strong government policies in Germany promote voluntary donation and help maintain a robust, stable supply chain. Research on platelet storage and pathogen-reduction technologies has enhanced safety and significantly reduced platelet wastage. Overall, Germany’s commitment to quality and innovation makes it a key contributor to the European platelet market’s growth.
   

Asia Pacific Blood Platelets Market

The Asia Pacific market accounted for the majority share in the market and was valued at USD 2.1 billion in 2024.
 

• Rapid growth in platelet demand is observed in the Asia Pacific, driven by developing healthcare infrastructure, a high regional population, and a rise in surgical volumes. China, Japan, and India lead the regional market.
   
• Japan has a centralized system that focuses on achieving near-total national coverage, while in China, the Red Cross plays a key role in addressing the country's blood component requirements. India faces supply challenges due to its fragmented structure, but constant efforts through awareness campaigns and regional blood banks are improving the situation. For example, in November 2023, Abbott, a key global medical devices and healthcare solutions company, under its global program BETHE1, launched an awareness campaign to inspire India’s young population to donate blood. The initiative has witnessed a positive response throughout the country, promoted by its campaign song ‘Give Blood. Get Good Vibes.’
   
• Further, the rise in the target population suffering from various chronic diseases and trauma cases correlates with increasing platelet utilization. Technological adoption is also rising, with automated platelet collection systems gaining popularity in developed economies.
   

China blood platelets market is estimated to grow with a robust CAGR, in the Asia Pacific market.
 

• China’s platelet market is expanding rapidly due to its large population, rising surgical procedures, and increasing cancer prevalence. Urban hospitals are equipped with advanced technologies such as automated apheresis systems and pathogen-reduction methods, ensuring a high-quality platelet supply.
   
• Government initiatives promoting voluntary blood donation and strict safety regulations further strengthen the system.
   
• Growing investments in healthcare infrastructure and research into synthetic platelets and extended shelf-life solutions highlight China’s focus on innovation. The combination of high demand and modernization makes the country a critical growth market.
   

Latin America Blood Platelets Market

Brazil leads the Latin American market, exhibiting remarkable growth during the analysis period.
 

• Brazil’s platelet market is driven by rising trauma cases, elective surgeries, and a growing burden of chronic diseases. The Brazilian Red Cross and regional blood banks dominate collection, but supply gaps persist in remote areas.
   
• Urban hospitals increasingly adopt advanced storage and pathogen-reduction technologies, while rural regions rely on traditional methods. In addition, public health campaigns and government programs encourage voluntary donations, improving availability.
   
• Additionally, healthcare modernization and partnerships with international organizations are enhancing safety standards and operational efficiency in the country.
   

Middle East and Africa Blood Platelets Market

Saudi Arabia market to experience substantial growth in the Middle East and Africa market in 2024.
 

• Saudi Arabia’s platelet market is growing steadily, supported by significant investments in healthcare infrastructure and modern hospitals. Rising surgical volumes, an increasing number of patients with hemophilia, and the growing prevalence of chronic diseases are driving platelet demand.
   
• Additionally, the government promotes voluntary donations through awareness campaigns and ensures compliance with strict safety standards. Advanced technologies such as automated apheresis systems and pathogen-reduction methods are being integrated into major hospitals, improving efficiency and reducing infection risks.
   
• Strategic collaborations with global organizations are contributing to enhanced training and technology transfer. Further, with a focus on healthcare modernization and innovation, Saudi Arabia is emerging as a leading player in the Middle East region.
   

Blood Platelets Market Share

The market is fragmented and consists of individual nonprofit groups, national blood service societies, and regional networks that manage the majority of collection and transfusion activities. Some of the key organizations include the American National Red Cross, America’s Blood Centers, the Indian Red Cross Society, Canadian Blood Services, the Japanese Red Cross Society, and the European Blood Alliance (EBA). These organizations have large networks of donors and the necessary infrastructure to collect, store, and distribute blood platelets.
 

In addition, advanced automation and pathogen reduction technologies are common in developed regions to ensure safe and efficient blood collection. Emerging markets such as India, Brazil, and other countries rely on regionally located blood banks and governmental initiatives to improve their supply chains.
 

Further, collaborative approaches between blood services and healthcare include proposals to engage donors, digital systems for inventory management, and research toward synthetic platelets. While nonprofit organizations continue to play a critical role in the market, private healthcare providers and some biotech organizations are gradually entering the market with platelet-related innovations such as platelet-rich plasma therapies and extended-shelf-life solutions. The competitive structure emphasizes reliability, safety, and accessibility. The adoption of technological solutions and educational campaigns is anticipated to be important for future growth.
 

Blood Platelets Market Companies

Few of the prominent players operating in the global blood platelets industry include:

• American Association of Blood Banks (AABB)
• American National Red Cross
• America's Blood Centers
• Blood Centers of America
• Brazilian Red Cross
• Canada Blood Services
• French Red Cross
• German Red Cross
• Indian Red Cross Society
• Italian Red Cross
• Japanese Red Cross Society
• OneBlood
• Red Cross Society of China
• South African Red Cross
• Spanish Red Cross
• The European Blood Alliance (EBA)
• The Italian National Blood Centre
   
• America’s Blood Centers (ABC)

Focuses on strengthening community-based blood collection networks, leveraging digital platforms for donor engagement, and implementing advanced inventory management systems to ensure timely platelet availability across its decentralized centers.
 

• The European Blood Alliance (EBA)

Promotes collaboration among European blood services, harmonizes safety standards, and supports research into innovative platelet technologies, enabling a sustainable supply chain and improved transfusion practices across member countries.
 

• Japanese Red Cross Society

Operates a centralized blood service model emphasizing donor retention programs, advanced screening technologies, and automation in platelet collection to uphold high safety standards and meet increasing healthcare demands.
 

Blood Platelets Industry News:

• In May 2025, America’s Blood Centers (ABC) and the American College of Surgeons (ACS) announced a new national collaboration during National Trauma Awareness Month. Under the collaboration, both the entities will focus on two critical aspects of trauma care: equipping individuals with life-saving skills to control severe bleeding in emergencies and highlighting importance of blood donation by ensuring blood products are available whenever they are required.
   
• In February 2023, Blood Centers of America (BCA) and Bluejay Diagnostics, Inc. announced a collaboration to develop commercial products by using the Symphony platform to address
   
• unmet requirements in the blood and hospital sectors. This partnership allowed the company to implement innovation that helps support the sustainability of the blood supply.
   
• In September 2022, Grifols and Canadian Blood Services announced they had signed a long-term agreement to drive the country's self-sufficiency in immunoglobulin (Ig) medicines, essential plasma protein therapies that are used to treat a wide range of immunodeficiencies and other medical conditions. This collaboration agreement helped the organizations in their long-term growth strategy.
   

The global blood platelets market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue (USD Million) and volume (Units) from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Platelet Type

• Whole-blood derived platelet
• Apheresis derived platelets

Market, By Application

• Hemophilia
• Thrombocytopenia
• Perioperative indications
• Platelet function disorders
• Hemato-oncology
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE